Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Gabathuler

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 29, 2025
Efficacy of Aflibercept 8 mg in Pretreated Age-Related Macular DegenerationChristiane Palm, Sandrine Anne Zweifel, Felix Gabathuler, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 20, 2026
Real-World Case Series of Intravitreal Pegcetacoplan for Geographic Atrophy Secondary to Age-related Macular Degeneration in SwitzerlandFelix Gabathuler, Mariano Cozzi, Katrin Fasler, et al.
Journal of Bioethical Inquiry|July 29, 2025
Reflections on Epistemic Injustice to Advance Person-Centred Care Through the Experiences of Persons with Chronic PainFelix Gabathuler, Kristina Würth, Martina Hodel, et al.
Retinal Cases & Brief Reports|April 13, 2026
Misfolded Proteins in the Eye - Vitreous AmyloidosisKatrin Fasler, Eléonore Multone, Marc Stahel, et al.
BMJ Open Ophthalmology|January 30, 2026
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network reportAmr Saad, Christina Plasencia, Justus Garweg, et al.
Ophthalmology and Therapy|February 3, 2026
One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportGabriela Grimaldi, Nicolò Bartolomeo, Justus G Garweg, et al.
Ophthalmology and Therapy|March 4, 2026
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportAlice M Kitay, Anne Tillmann, Isabel Pfister, et al.
Ophthalmology Science|March 5, 2026
Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network ReportJan Spindler, Dmitri Artemiev, Isabel B Pfister, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 29, 2025
Efficacy of Aflibercept 8 mg in Pretreated Age-Related Macular DegenerationChristiane Palm, Sandrine Anne Zweifel, Felix Gabathuler, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 20, 2026
Real-World Case Series of Intravitreal Pegcetacoplan for Geographic Atrophy Secondary to Age-related Macular Degeneration in SwitzerlandFelix Gabathuler, Mariano Cozzi, Katrin Fasler, et al.
Journal of Bioethical Inquiry|July 29, 2025
Reflections on Epistemic Injustice to Advance Person-Centred Care Through the Experiences of Persons with Chronic PainFelix Gabathuler, Kristina Würth, Martina Hodel, et al.
Retinal Cases & Brief Reports|April 13, 2026
Misfolded Proteins in the Eye - Vitreous AmyloidosisKatrin Fasler, Eléonore Multone, Marc Stahel, et al.
BMJ Open Ophthalmology|January 30, 2026
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network reportAmr Saad, Christina Plasencia, Justus Garweg, et al.
Ophthalmology and Therapy|February 3, 2026
One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportGabriela Grimaldi, Nicolò Bartolomeo, Justus G Garweg, et al.
Ophthalmology and Therapy|March 4, 2026
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportAlice M Kitay, Anne Tillmann, Isabel Pfister, et al.
Ophthalmology Science|March 5, 2026
Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network ReportJan Spindler, Dmitri Artemiev, Isabel B Pfister, et al.
Pageof 1